Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Corneal toxicity with belantamab mafodotin: Multi-institutional real-life experience.
Journal: American journal of hematology
Published: July 04, 2022
Clinical efficacy of sequencing CD38 targeting monoclonal antibodies in relapsed refractory multiple myeloma: A multi-institutional experience.
Journal: American journal of hematology
Published: February 26, 2022
Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma.
Journal: American journal of hematology
Published: January 25, 2022
Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission.
Journal: Journal of clinical medicine
Published: January 06, 2022
Hematological and infectious complications with CD38 antigen targeting monoclonal antibody-based therapies in multiple myeloma: A meta-analysis of randomized control trials.
Journal: Leukemia research
Published: July 29, 2021
Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma.
Journal: Cancers
Published: July 06, 2021
Persistent bone marrow minimal residual disease as a "high-risk" disease feature in multiple myeloma.
Journal: American journal of hematology
Published: April 17, 2021
Predicting risk of progression in relapsed multiple myeloma using traditional risk models, focal lesion assessment with PET-CT and minimal residual disease status.
Journal: Haematologica
Published: April 12, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026